The Malaria Consortium achieved a record income in 2021/22, thanks to grants worth tens of millions of pounds from US foundations.
The charity raised £84.4m in the year to March 2022, a sharp rise compared with £67.9m in 2020/21.
It spent £79.8m, up from £66.8m, and recorded a surplus of £4.7m, according to accounts filed last week with Companies House.
The extra income was driven by a new multimillion-pound grant from the California-based Silicon Valley Community Fund and increased giving from the US-based philanthropy firm Good Ventures.
The Malaria Consortium received £11.9m from the Silicon Valley Community Fund, while the value of grants from Good Ventures rose from £18.6m to £38.8m.
The Bill and Melinda Gates Foundation, which has invested heavily in preventing and eradicating malaria around the world, gave the charity £4m in 2021/22 compared with £2.9m in 2020/21.
The charity’s main headquarters are in London, but it also has offices in the US and many of the countries in which it operates, including Uganda, Nigeria and Ethiopia.
Unrestricted reserves are £10.8m, up from £6.1m in 2020/21.
A spokesperson for the charity said: “This income will enable us to achieve even greater health impact, especially through interventions like seasonal malaria chemoprevention, and particularly with the World Health Organization reporting stalled progress in moving towards malaria elimination in the last few years.”
Writing in the annual report, the charity’s trustees thanked the “effective philanthropy community” for its support, and said the funding “enables us to see consistency in our ability to intervene and a degree of financial certainty in uncertain times”.